康寶萊 HLF 深 滬
已收盤 08-22 16:00:00 美东时间
9.74
+0.560
+6.10%
華盛通- 最 高9.755
- 今 開9.28
- 成交量 126.17万股
- 最 低 9.28
- 昨 收 9.18
- 總市值 10.03亿
- 52周最高 10.83
- 市盈率 靜 3.89
- 換手率 1.22%
- 52周最低 5.04
- 委 比 -88.20%
- 總股本 1.03亿
- 歷史最高 61.77
- 量 比 0.81
- 振 幅 5.17%
- 歷史最低 5.04
- 每 手 1
- 風險率 1.13%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多正品控股港股IPO，聚焦香港保健及美容品市场，毛利率逐年下滑
疫情后，许多人对健康愈发重视，加上人口老龄化的加剧，保健品市场规模逐渐提升。在草姬集团港股上市后，又有香港的保健品公司冲击IPO。 格隆汇获悉，近日，正品控股有...
08-14 18:51
High Liner Foods’ Earnings Call: Mixed Results and Future Prospects
High Liner Foods (($TSE:HLF)) has held its Q2 earnings call. Read on for the ma...
08-13 08:49
High Liner Foods Q2 Adj. EPS $0.38 Misses $0.46 Estimate, Sales $239.61M Beat $239.09M Estimate
High Liner Foods (TSX:HLF) reported quarterly earnings of $0.38 per share which missed the analyst consensus estimate of $0.46 by 17.39 percent. This is a 8.57 percent increase over earnings of $0.35 per share from the
08-08 05:26
Herbalife Raises FY2025 Sales Guidance from $4.868B-$5.118B to $4.943B-$5.143B vs $4.948B Est
Herbalife (NYSE:HLF) raises FY2025 sales outlook from $4.868 billion-$5.118 billion to $4.943 billion-$5.143 billion vs $4.948 billion estimate.
08-07 04:52
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Herbalife Earnings Preview
Herbalife (NYSE:HLF) is gearing up to announce its quarterly earnings on Wednes...
08-06 02:02
Mizuho Maintains Neutral on Herbalife, Raises Price Target to $9
Mizuho analyst John Baumgartner maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $8 to $9.
07-28 19:09
High Liner Foods to Announce Q2 2025 Earnings
High Liner Foods ( ($TSE:HLF) ) just unveiled an announcement. High Liner Foods...
07-24 23:08
从口服美容降温到细分赛道崛起：保健品市场的新变局
（来源：摩熵医药大数据） 当办公室里的年轻人开始在抽屉里囤积护眼胶囊，小区的长辈们讨论着最新的补钙产品，直播间里的保健品专场总能引来数万次点击，这些日常景象的...
07-23 14:27
Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide
UnitedHealthcare, the largest commercial insurer in the U.S., has announced comprehensive coverage for Heartflow Plaque Analysis, an AI-enabled tool for precise diagnosis and management of coronary artery disease (CAD). This decision aligns with recent guidelines from radiology benefit manager EviCore and will take effect on October 1, 2025, for patients with chest pain and mild-to-moderate coronary artery narrowing. Heartflow Plaque Analysis, th...
07-22 22:28
